Review Article
Focus on Therapeutic Strategies of Nonalcoholic Fatty Liver Disease
Table 1
Synthesis of possible targets of therapeutic strategies in use and in study for NAFLD. Focus on biochemical, ultrasonographic, and histological features of NAFLD: altered levels of transaminases, steatosis, necroinflammation, and fibrosis.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
*Target not clear. PUFA: -3 polyunsaterated fatty acids; TZDs: thiazolidinediones; ARBs: angiotensin II type 1 receptor blockers; UDCA: ursodeoxycholic acid; GTE: green tea extract; PXR: pregnane X receptor; FXR: farnesoid X receptor. |